Jake Bauer - 23 Feb 2023 Form 3 Insider Report for Enliven Therapeutics, Inc. (ELVN)

Role
Director
Signature
/s/ Ben Hohl, by power of attorney
Issuer symbol
ELVN
Transactions as of
23 Feb 2023
Net transactions value
$0
Form type
3
Filing time
27 Feb 2023, 20:44:19 UTC
Previous filing
12 Jul 2021
Next filing
20 Feb 2024

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney